Stay updated on GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Sign up to get notified when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.

Latest updates to the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page
- Check5 days agoChange DetectedThe page continues to display a 403 Forbidden error. The footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces an NIH terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check19 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe site footer’s revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating restricted access to the content. The study record area is replaced by an access error message rather than displaying the study details.SummaryDifference19%

- Check68 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a new version of the page content. This is a backend/content update and does not change the study details or other user-facing information.SummaryDifference0.1%

Stay in the know with updates to GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Enter your email address, and we'll notify you when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.